Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Benefits and Harms of Pharmacologic Treatments in Adults With Overweight or Obesity: A Living Systematic Review and Network Meta-analysis for the American College of Physicians
Damen JAA, Idema DL, Vernooij RWM, et al.
Annals of internal medicine, 2026
Pharmacologic Treatments With Lifestyle Modifications in Nonpregnant Adults With Overweight or Obesity in Outpatient Settings: A Living Clinical Guideline From the American College of Physicians (April 2026)
Qaseem A, Cross JT, Harrod CS, et al.
Annals of internal medicine, 2026
Cardiovascular Outcomes in a SELECT-Like Obesity Cohort: Real-World Insights From the Swedish AROS Database
Ritsinger V, Fagerström J, Nero H, et al.
Diabetes, obesity & metabolism, 2026
Tirzepatide for Excess Weight in Adults With Type 1 Diabetes Using MiniMed 780G
De Fano M, Tortoriello R, Rucco S, et al.
Diabetes, obesity & metabolism, 2026
Comparative Effects of Antidiabetic Drugs on Body Composition: A Systematic Review and Network Meta-Analysis
Rakhsha SS, Shahinfar H, Ebrahimi-Mousavi S, et al.
Diabetes, obesity & metabolism, 2026
Tirzepatide for Obesity in Adults ≥ 65 Years: A Post Hoc Analysis of the SURMOUNT and SUMMIT Clinical Trials
Alfaris N, Kushner RF, Li J, et al.
Diabetes, obesity & metabolism, 2026
Comparison of Specific Glucagon-Like Peptide-1 Receptor Agonists on Kidney Outcomes Among Patients With Type 2 Diabetes
Neumiller JJ, Deng Y, Swarna KS, et al.
American journal of kidney diseases : the official journal of the National Kidney Foundation, 2026
Association between GLP-1 receptor agonist use and NAION with optic disc drusen
Abboud I, Madani R, Chacko JG, et al.
Ophthalmology, 2026
Weight-loss dynamics with tirzepatide versus semaglutide
Venkatakrishnan AJ, Murugadoss K, Soundararajan V
PNAS nexus, 2026;5(6):pgag171
Tirzepatide and the Cardiovascular Continuum: Metabolic, Cardiorenal and Heart Failure Evidence
Parlati AL, Martini L, Nardi E, et al.
Clinical Medicine Insights. Cardiology, 2026;20:11795468261460202
Prospects for Neuroprotective Therapies in Glaucoma: Drug Targets and Emerging Clinical Strategies
Rho S, Williams PA
Drug design, development and therapy, 2026;20:612176
Prioritizing Antidiabetic Drugs for Inflammatory Bowel Disease Through Inverse Signal Detection: A FAERS Pharmacovigilance Study
Đogatović K, Vučićević K, Marković S, et al.
Journal of clinical medicine, 2026;15(12)
Urological Complications of Morbid Obesity and the Role of Bariatric Surgery and Glucagon-Like Peptide-1 Receptor Agonists in Their Management: A Systematic Review
Khalil W, Bibi K, Fareed T, et al.
Cureus, 2026;18(6):e110952
Acute Nutritional Axonal Neuropathy in the Setting of Semaglutide-Associated Gastrointestinal Intolerance: A Case Report
Cohan CJ, Townley L, Ortega E
Case reports in neurology, 2026;18(1):402-412
Real-world use of oral semaglutide in adults with type 2 diabetes
Roslind K, Bodholdt U, Damgaard T, et al.
Danish medical journal, 2026;73(7)
Cardiometabolic Effects of Semaglutide in Individuals with Type 2 Diabetes in the United Arab Emirates: Real-World 12-Month Outcomes and Predictors of Response
Mian MHS, Janahi KAHA, Tayeb A, et al.
Diabetes therapy : research, treatment and education of diabetes and related disorders, 2026
GLP-1 Receptor Agonists in Aesthetic Surgery: A Narrative Review on Perioperative Safety, Sarcopenic Morphologies, and Adapted Body Contouring Strategies
Venza M, Venza I
Aesthetic plastic surgery, 2026
Temporal Trends and Clinical Characteristics of Incretin-Based Therapy Use in Women With Polycystic Ovary Syndrome: A Real-World Cohort Study From a Polish Private Healthcare Network
Dziewierz A, Kulicka N, Stolarska K, et al.
Diabetes, obesity & metabolism, 2026
Electrospun Nanofiber Oral Thin Film Platform for Sublingual Peptide Delivery: A Promising Alternative to Conventional Semaglutide Formulations
Sagar G, Stránská V, Stránská D, et al.
Diabetes, obesity & metabolism, 2026
The Effect of Semaglutide on Quality of Life in Adults With Overweight or Obesity: A Brief Systematic Review and Meta-Analysis
Eisa N, Khoury M
Diabetes, obesity & metabolism, 2026